(2001) Recent advances in the treatment of AML. Hematological Oncology 19 :10.1002/hon.v19:3, 107-118 /M.Macheta, J. A.Liu Yin. (2001) Recent advances in the treatment of AML. Hematological Oncology 19 :10.1002/hon.v19:3, 107-118 /...
For instance, when evaluating the efficacy or cost-effectiveness of a treatment for reimbursement, the government requires data on improvement in overall survival (OS) as the gold standard. Still, OS data is almost impossible to obtain for AML treatments that aim for a cure through hematopoietic ...
11,12 The 20% blast threshold was eliminated from the diagnostic criteria based on the fact that the NPM1-mutated myeloid neoplasms with less than 20% blasts are associated with shorter survival compared with wild-type cases and can benefit most from upfront intensive (AML-type) treatment ...
In-person and virtual events just for HCPs Choose Specialty EP. 13:Relapsed/Refractory FLT3-Mutated AML January 29th 2020 EP. 14:IDH1/2 Inhibitors in AML January 29th 2020 EP. 15:Differentiation Syndrome and IDH1/2 Inhibitors January 29th 2020 ...
treatment options, several questions arise such as how to best sequence therapy, how to combine therapies, and if there is a role for maintenance therapy in those who achieve remission and cannot undergo alloHSCT. Moreover, certain subtypes of AML, such as those withTP53mutations, still have ...
Over the past ten years, there have been substantial advances in the treatment of AML. Intensive induction chemotherapy using seven-day courses of cytarabine and daunorubicin or amsacrine produce remission in 60-85% of patients. Median remission duration is 9-16 months. In some series, 20-40% ...
期刊名称:《Advances in medical sciences.》|2015年第2期 关键词: Melanoma; Metastasis; Treatment; Targeted therapy; Immunotherapy; 32.Metamorphopsia before and after full-thickness macular hole surgery 机译:全厚度黄斑裂孔术前后变态 作者:Krasnicki Pawel;Dmuchowska Diana Anna;Pawluczuk Barbara;Proniew...
John M. Burke, MD, expands on the use of novel BTK inhibitor regimens in mantle cell lymphoma, treatment sequencing challenges and other unmet needs in diffuse-large B-cell lymphoma, the evolution of management strategies for myeloproliferative neoplasms
Methods: To evaluate the prognostic value of endostatin serum level in acute myeloid leukemia (AML), sixty subjects were included in this study, 30 apparently healthy adult subjects as control (group I) and 30 adult patients with newly diagnosed de novo AML (group II). Estimation of serum end...
In their experience the outcomes with this procedure were comparable to HLA-identical sibling transplantation [36,37]. The same group published the results of a prospective trial in patients with intermediate or high risk Acute Myeloid Leukemia (AML) in first complete remission (CR1) that showed ...